Infertility Clinical Trial
Official title:
Trajectory of Psychological Distress Among Infertility Women: Efficacy and Mechanism of Mind-body Intervention With Heart Rate Variability Biofeedback
NCT number | NCT04829877 |
Other study ID # | N201807030 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 19, 2022 |
Est. completion date | January 2024 |
Background: Infertility is a serious reproductive health issue and affects 48.5 million couples worldwide. Women undergoing fertility treatment often experienced psychological distress but also social stigma that is close linked to later pregnancy outcome. Despite the advancement in assisted reproductive technology, effective interventions for reducing stress, anxiety, and depressive symptoms for infertility women remain lacking. Objectives: The objective of this proposal is to evaluate the efficacy of web-based mind-body intervention combining HRV biofeedback on the infertility women's anxiety symptoms, levels of depression, HRV function, mindful awareness, infertility self-efficacy, and pregnancy rates. Methods: We plan to conduct a randomized controlled trial on the web-based mind-body intervention combining heart rate variability biofeedback. Eligible women will be recruited and randomized into three groups. Intention-to-treat analysis and mixed regression modeling will be used to estimate the effectiveness of the interventions. Anticipatory results: Effective strategies will be determined for infertility women.
Status | Recruiting |
Enrollment | 750 |
Est. completion date | January 2024 |
Est. primary completion date | January 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 20 Years to 60 Years |
Eligibility | Inclusion Criteria: - 20-year-old and above - Seeking infertility care - Contemplating pregnancy - Intended to start their ART cycle - Able to speak Taiwanese or Mandarin Exclusion Criteria: - Diagnosis of cardiovascular disease, depressive disorder, anxiety disorder, cardiac arrhythmia - Already had started their ART treatment - Taking medications that might affect ANS activity |
Country | Name | City | State |
---|---|---|---|
Taiwan | Infertility clinic | Taipei |
Lead Sponsor | Collaborator |
---|---|
Taipei Medical University |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Anxiety | Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). | Baseline | |
Primary | Anxiety | Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). | 1 week post-intervention | |
Primary | Anxiety | Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). | 1 month post-intervention | |
Primary | Anxiety | Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). | 2 month post-intervention | |
Primary | Anxiety | Anxiety symptoms will be assessed using the Taiwanese version of the State Anxiety Inventory (SAI). | 3 month post-intervention | |
Secondary | Depressive symptoms | The Taiwanese version of the Beck Depression Inventory (BDI) will be used to assess depressive symptoms among infertility women. | Baseline, post-intervention 1 week, month 1 , 2 and 3 | |
Secondary | HRV function | The HRV signal will be measured using standard equipment. | Baseline, post-intervention 1 week, month 1 , 2 and 3 | |
Secondary | Mindful awareness | The Taiwanese version of the Five Facet Mindfulness Questionnaire (FFMQ) will be adopted to assess levels of mindfulness. | Baseline, post-intervention 1 week, month 1 , 2 and 3 | |
Secondary | Infertility self-efficacy | The infertility Self-Efficacy Scale (ISE) will be used for studied women. | Baseline, post-intervention 1 week, month 1 , 2 and 3 | |
Secondary | Pregnancy rates | Clinical pregnancy will be defined as a positive blood, urinary pregnancy test. | 15 days after embryo transfer or ultrasound |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03607409 -
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
|
||
Recruiting |
NCT02312076 -
GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles
|
Phase 4 | |
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Completed |
NCT03287479 -
Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®)
|
N/A | |
Terminated |
NCT03522350 -
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
|
N/A | |
Completed |
NCT04496284 -
Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen
|
N/A | |
Completed |
NCT03623659 -
pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts
|
N/A | |
Completed |
NCT03895099 -
New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors
|
Phase 3 | |
Active, not recruiting |
NCT04142112 -
Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation
|
N/A | |
Completed |
NCT03152643 -
Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer
|
N/A | |
Recruiting |
NCT03683771 -
Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
|
||
Recruiting |
NCT03161119 -
Comparing Two Different Embryo Transfer Catheters
|
N/A | |
Completed |
NCT04108039 -
Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.
|
N/A | |
Completed |
NCT03678571 -
Oocyte Vitrification Aided With Latrunculin A
|
N/A | |
Completed |
NCT03678558 -
Oocyte Vitrification Aided With Cytochalasin B
|
N/A | |
Completed |
NCT03677492 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD)
|
N/A | |
Completed |
NCT03678584 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
|
N/A | |
Completed |
NCT03678597 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB)
|
N/A | |
Completed |
NCT03678818 -
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA)
|
N/A | |
Completed |
NCT03678610 -
Handling Medium for ICSI With Ionomycin and Latrunculin A
|
N/A |